Marrone Anna, Walne Amanda, Dokal Inderjeet
Department of Haematology, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
Curr Opin Genet Dev. 2005 Jun;15(3):249-57. doi: 10.1016/j.gde.2005.04.004.
Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome that displays marked clinical and genetic heterogeneity. The identification of dyskeratosis congenita gene 1 (DKC1) mutations in X-linked recessive patients initially suggested that DC is a defective pseudouridylation disorder. The subsequent identification of mutations in the telomerase RNA component (TERC) of autosomal dominant DC patients together with the discovery that both TERC and the DKC1-encoded protein, dyskerin, are closely associated in the telomerase complex have suggested that the pathophysiology of DC predominantly relates to defective telomere maintenance. Recent discoveries have shown that autosomal dominant DC exhibits disease anticipation and that this is associated with progressive telomere shortening owing to the haplo-insufficiency of TERC.
先天性角化不良(DC)是一种罕见的骨髓衰竭综合征,具有显著的临床和遗传异质性。在X连锁隐性患者中鉴定出先天性角化不良基因1(DKC1)突变,最初提示DC是一种有缺陷的假尿苷酸化障碍。随后在常染色体显性DC患者的端粒酶RNA组分(TERC)中鉴定出突变,同时发现TERC和DKC1编码的蛋白质盘状结构域蛋白(dyskerin)在端粒酶复合物中紧密相关,这提示DC的病理生理学主要与端粒维持缺陷有关。最近的发现表明,常染色体显性DC表现出疾病早现现象,并且这与由于TERC单倍体不足导致的端粒进行性缩短有关。